Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative Oncology in Practice: Moving the SIO-ASCO Guidelines From Evidence to Implementation.

Seminars in radiation oncology·2026
Same author

Integrative Oncology for Prostate Cancer: A Narrative Review.

Seminars in radiation oncology·2026
Same author

Complementary and integrative medicine therapy in a hematology division: a retrospective study.

Leukemia & lymphoma·2026
Same author

Authors' Reply: Gestational Diabetes as a Window into Underdocumented CKD in Women.

Journal of the American Society of Nephrology : JASN·2026
Same author

Factors associated with patient adherence to medical recommendations during a health crisis.

PloS one·2026
Same author

Divergent effects of PLA2G7 on prostate cancer biochemical recurrence in European American and African American men.

Journal of the National Cancer Institute·2026
Same journal

Coping with Breathlessness in Individuals with Lung Diseases: A Systematic Review and Meta-Synthesis.

Journal of pain and symptom management·2026
Same journal

Growing the Next Generation of Hospice and Palliative Medicine Researchers.

Journal of pain and symptom management·2026
Same journal

Topical Amitriptyline, Ketamine, and Lidocaine Cream for Neuropathic Pain Control in Pediatric Oncology Patients.

Journal of pain and symptom management·2026
Same journal

Perceived Stigma, Psychological Distress, and Symptom Burden in Decompensated Cirrhosis.

Journal of pain and symptom management·2026
Same journal

Routine Urine Drug Screening in Palliative Care - A Call for Evidence Before Implementation.

Journal of pain and symptom management·2026
Same journal

Why We Should Rarely Override Surrogates.

Journal of pain and symptom management·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Developing a Preliminarily Validated Competency-Based Integrative Oncology Training Questionnaire.

Eran Ben-Arye1, Orit Gressel1, Elad Schiff2

  • 1The Ruth and Bruch Rappaport Faculty of Medicine (E.B.A., O.G., E.S., M.A.M.), Technion-Israel Institute of Technology, Haifa, Israel; Integrative Oncology Program, The Oncology Service, Lin, Carmel, and Zebulun Medical Centers (E.B.A., O.G.), Clalit Health Services, Haifa, Israel.

Journal of Pain and Symptom Management
|May 18, 2026
PubMed
Summary
This summary is machine-generated.

A new questionnaire, the Core Clinical Integrative Oncology Competencies (CCC-IO), was developed and validated to assess healthcare provider trainees. The CCC-IO tool demonstrates high reliability and validity for evaluating baseline integrative oncology competencies.

Keywords:
Integrative oncologycancercompetency-based medical educationintegrative medicinequestionnairevalidation

Related Experiment Videos

Last Updated: May 20, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Area of Science:

  • Integrative Oncology
  • Medical Education
  • Healthcare Provider Training

Background:

  • Implementing clinical integrative oncology (IO) guidelines necessitates comprehensive training for healthcare providers (HCPs).
  • Assessing core competencies is crucial for effective IO training programs.
  • Existing assessment tools may not fully capture the breadth of IO knowledge and skills required by trainees.

Purpose of the Study:

  • To develop and preliminarily validate a questionnaire assessing baseline core clinical IO competencies (CCC-IO) among HCP trainees.
  • To evaluate the reliability and construct validity of the CCC-IO tool.
  • To establish a benchmark for assessing IO training program effectiveness.

Main Methods:

  • A multi-disciplinary international team developed the CCC-IO questionnaire.
  • A cross-sectional study nested within a randomized controlled trial examined reliability (Cronbach's alpha) and validity (exploratory factor analysis).
  • 109 HCP trainees completed baseline questionnaires assessing 20 IO-related competencies across five domains.

Main Results:

  • Exploratory factor analysis confirmed five domains, with 'Anxiety Relief' having the highest explanatory power (52.39%).
  • The CCC-IO tool demonstrated high reliability, with Cronbach's alpha ranging from 0.78 to 0.97 across domains and 0.95 for the entire cohort.
  • No significant between-group differences were observed in baseline characteristics or competency scores.

Conclusions:

  • The CCC-IO tool is a reliable and valid instrument for assessing baseline clinical competencies in HCP trainees undergoing intensive IO training.
  • The tool supports the baseline assessment of core clinical IO competencies.
  • Further research is recommended to evaluate the CCC-IO tool in diverse palliative care settings, cultures, and languages.